The increasing consumer demand for natural and mild formulations without compromising any performance remains a key challenge for cosmetic formulators. A breakthrough in fermentation technology now enables the commercial production of nature-identical glycolipids generated entirely from sugars. By combining both gentle cleansing and excellent foam properties with unprecedented environmental compatibility, RHEANCE® Glycolipids indicates a new dimension of formulating. Born from Evonik’s latest innovative technology platform, RHEANCE® Glycolipids is a new class of all-natural ingredients produced with a unique fermentation process, representing a sustainable step change in cosmetic ingredients technology.
RHEANCE® One, a breakthrough in natural cleansing, is the first ever glycolipids product worldwide. It is made from pure renewable and responsibly sourced sugar without any carbon sources or tropical oil. This brand-new all-natural ingredient is perfectly suitable for rinse-off applications and intended for cleansing, solubilizing and foaming additive in gentle personal cleansing formulations. Since its launch in 2018, the product has already been awarded with the Gold Medal for Best Functional Ingredients both at in-Cosmetics Global and in-Cosmetics Asia 2018.
“We are proud to be recognized for delivering products and solutions that create value and competitive advantage for our customers. Evonik is committed to contributing to the industry by creating high performance, environmentally friendly and sustainable solutions.” said Evan Wu, Vice President of Evonik Care Solutions Asia Pacific.
The Ringier Technology Innovation Award recognizes innovative products and technologies that have made outstanding contributions in the industry through technical innovation, improved productivity and economic efficiency. The award is among the most prestigious awards in China’s personal care industry.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
Evonik’s international activities are organized into six regions. The Asia Pacific North region is headquartered in Shanghai. Sales from continuing operations in Asia Pacific North reached €1.97 billion in 2018. Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs over 2,500 employees and has in total of 10 production sites in China.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.